| | Editorial Do nurses do it better? S Rafferty and J Elborn Thorax. 2002 August; 57(8): 659–660. doi: 10.1136/thorax.57.8.659.PMCID: PMC1746398 Original Articles A randomised controlled crossover trial of nurse practitioner versus doctor led outpatient care in a bronchiectasis clinic L Sharples, J Edmunds, D Bilton, W Hollingworth, N Caine, M Keogan, and A Exley Thorax. 2002 August; 57(8): 661–666. doi: 10.1136/thorax.57.8.661.PMCID: PMC1746394 Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis I Woolhouse, D Bayley, and R Stockley Thorax. 2002 August; 57(8): 667–671. doi: 10.1136/thorax.57.8.667.PMCID: PMC1746392 Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment F Blasi, S Damato, R Cosentini, P Tarsia, R Raccanelli, S Centanni, and L Allegra Thorax. 2002 August; 57(8): 672–676. doi: 10.1136/thorax.57.8.672.PMCID: PMC1746406 Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma N Carroll, S Mutavdzic, and A James Thorax. 2002 August; 57(8): 677–682. doi: 10.1136/thorax.57.8.677.PMCID: PMC1746401 Respiratory medications and risk of asthma death S Lanes, R Garcia, and C Huerta Thorax. 2002 August; 57(8): 683–686. doi: 10.1136/thorax.57.8.683.PMCID: PMC1746414 Effect of nitrogen dioxide and ozone on the risk of dying in patients with severe asthma J Sunyer, X Basagana, J Belmonte, and J Anto Thorax. 2002 August; 57(8): 687–693. doi: 10.1136/thorax.57.8.687.PMCID: PMC1746405 Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness G Verhoeven, J Hegmans, P Mulder, J Bogaard, H Hoogsteden, and J Prins Thorax. 2002 August; 57(8): 694–700. doi: 10.1136/thorax.57.8.694.PMCID: PMC1746396 Diagnostic and treatment behaviour in children with chronic respiratory symptoms: relationship with socioeconomic factors M Ng, C Das, A Proctor, M Whyte, and R Primhak Thorax. 2002 August; 57(8): 701–704. doi: 10.1136/thorax.57.8.701.PMCID: PMC1746399 Respiratory symptoms and lung function in young adults with severe α1–antitrypsin deficiency (PiZZ) E Piitulainen and T Sveger Thorax. 2002 August; 57(8): 705–708. doi: 10.1136/thorax.57.8.705.PMCID: PMC1746413 Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of α1–antitrypsin deficiency and the role of leukotriene B4 and interleukin 8 I Woolhouse, D Bayley, and R Stockley Thorax. 2002 August; 57(8): 709–714. doi: 10.1136/thorax.57.8.709.PMCID: PMC1746407 Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support S Hand, S Edwards, I Campbell, and R Cannings Thorax. 2002 August; 57(8): 715–718. doi: 10.1136/thorax.57.8.715.PMCID: PMC1746389 A prospective study of change in bone mineral density over one year in adults with cystic fibrosis C Haworth, P Selby, A Horrocks, E Mawer, J Adams, and A Webb Thorax. 2002 August; 57(8): 719–723. doi: 10.1136/thorax.57.8.719.PMCID: PMC1746411 Patterns and predictors of sleep disordered breathing in primary myopathies R Ragette, U Mellies, C Schwake, T Voit, and H Teschler Thorax. 2002 August; 57(8): 724–728. doi: 10.1136/thorax.57.8.724.PMCID: PMC1746391 Review Series The pulmonary physician in critical care · 8: Ventilatory management of ALI/ARDS J Cordingley and B Keogh Thorax. 2002 August; 57(8): 729–734. doi: 10.1136/thorax.57.8.729.PMCID: PMC1746415 Chronic obstructive pulmonary disease • Introduction D Lomas Thorax. 2002 August; 57(8): 735. doi: 10.1136/thorax.57.8.735.PMCID: PMC1746404 Chronic obstructive pulmonary disease • 1: Susceptibility factors for COPD the genotype–environment interaction A Sandford and E Silverman Thorax. 2002 August; 57(8): 736–741. doi: 10.1136/thorax.57.8.736.PMCID: PMC1746410 Occasional Review "CF asthma": what is it and what do we do about it? I Balfour-Lynn and J Elborn Thorax. 2002 August; 57(8): 742–748. doi: 10.1136/thorax.57.8.742.PMCID: PMC1746393 Case Report Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis J Parmar, T Howell, J Kelly, and D Bilton Thorax. 2002 August; 57(8): 749–750. doi: 10.1136/thorax.57.8.749.PMCID: PMC1746400 Letters to the Editor IL-5 in asthma K Chung, E van Rensen, R Stirling, and P Barnes Thorax. 2002 August; 57(8): 751. doi: 10.1136/thorax.57.8.751.PMCID: PMC1746395 Bronchoconstrictor effect of deep inspiration in asthma G Sterling, G Gibson, and G Burns Thorax. 2002 August; 57(8): 751. doi: 10.1136/thorax.57.8.751-a.PMCID: PMC1746403 Inhaled sodium cromoglycate in children with asthma M Tasche, J Uijen, R Bernsen, J C de Jongste, and J C van der Wouden Thorax. 2002 August; 57(8): 751–752. doi: 10.1136/thorax.57.8.751-b.PMCID: PMC1746408 Body mass index and asthma I Eneli and W Karmaus Thorax. 2002 August; 57(8): 752. doi: 10.1136/thorax.57.8.752.PMCID: PMC1746402 Book Review Pulmonary Physiology and Pathophysiology W Kinnear Thorax. 2002 August; 57(8): 752. doi: 10.1136/thorax.57.8.752-a.PMCID: PMC1746409 Correction Thorax. 2002 August; 57(8): 752. doi: 10.1136/thorax.57.8.752-b.PMCID: PMC1746412 Corrects: D Ward, et al. Effects of daily variation in outdoor particulates and ambient acid species in normal and asthmatic children. Thorax. 2002 June; 57(6): 489–502. Journal Matter Original table of contents page |